KRAS and cancer: For example, the cancer vaccine ELI-002 2P consists of the amphiphile (Amph) modification of G12D- and G12R-mutant KRAS peptides (Amph-Peptide-2P) and a CpG oligonucleotide adjuvant (Amph-CpG-7909), which enhances lymph node delivery and the immune response.